Stefano Ciatto

Summary

Country: Italy

Publications

  1. pmc Reliability of PSA testing remains unclear
    Stefano Ciatto
    BMJ 327:750. 2003
  2. ncbi Role of double-contrast barium enema in colorectal cancer screening based on fecal occult blood
    Stefano Ciatto
    Centro per lo Studio e la Prevenzione Oncologica, Scientific Institute of Tuscany Region, Florence, Italy
    Tumori 88:95-8. 2002
  3. doi What is the best screening strategy to detect advanced colorectal adenomas? Simulation from ongoing Italian screening experiences
    Leonardo Ventura
    ISPO Cancer Research and Prevention Institute, Florence, Italy
    Tumori 97:547-50. 2011
  4. ncbi Accuracy of prostate volume measurements using transrectal multiplanar three-dimensional sonography
    Gianluca Giubilei
    Department of Urology, University of Florence, Florence, Italy
    Int J Urol 12:936-8. 2005
  5. ncbi Prostate cancer specific mortality in the Florence screening pilot study cohort 1992-1993
    Stefano Ciatto
    Centro per lo Studio e la Prevenzione Oncologica, Viale A Volta 171, 50131 Firenze, Italy
    Eur J Cancer 42:1858-62. 2006
  6. ncbi Current cancer profiles of the Italian regions: should cancer incidence be monitored at a national level?
    Stefano Ciatto
    Department of Diagnostic Imaging, CSPO, Istituto per la Prevenzione Oncologica, Florence, Italy
    Tumori 93:529-31. 2007
  7. ncbi Determining overdiagnosis by screening with DRE/TRUS or PSA (Florence pilot studies, 1991-1994)
    Stefano Ciatto
    Centro per lo Studio e la Prevenzione Oncologica, Viale A Volta 171, 50131 Florence, Italy
    Eur J Cancer 41:411-5. 2005
  8. ncbi Reliability of sparing Papanicolaou test conventional reading in cases reported as No Further Review at AutoPap-assisted cytological screening: survey of 30,658 cases with follow-up cytological screening
    Grazia Maria Troni
    Istituto Scientifico Prevenzione Oncologica CSPO, Florence, Italy
    Cancer 111:93-8. 2007
  9. ncbi PSA use and incidence of prostate biopsy in the Tuscany region: is opportunistic screening discounting biopsy in subjects with PSA elevation?
    Stefano Ciatto
    CSPO, Istituto Scientifico per la Prevenzione Oncologica, Florence, Italy
    Tumori 94:518-22. 2008
  10. ncbi Quality control of the autopap screening system employed as a primary screening device: rapid review of smears coded as no further review
    Paolo Bulgaresi
    Centro per lo Studio e la Prevenzione Oncologica, Florence, Italy
    Tumori 92:276-8. 2006

Collaborators

Detail Information

Publications29

  1. pmc Reliability of PSA testing remains unclear
    Stefano Ciatto
    BMJ 327:750. 2003
  2. ncbi Role of double-contrast barium enema in colorectal cancer screening based on fecal occult blood
    Stefano Ciatto
    Centro per lo Studio e la Prevenzione Oncologica, Scientific Institute of Tuscany Region, Florence, Italy
    Tumori 88:95-8. 2002
    ..The present study evaluated the contribution of double-contrast barium enema in detecting neoplastic lesions of the colon in fecal occult-blood-positive subjects with incomplete colonoscopy...
  3. doi What is the best screening strategy to detect advanced colorectal adenomas? Simulation from ongoing Italian screening experiences
    Leonardo Ventura
    ISPO Cancer Research and Prevention Institute, Florence, Italy
    Tumori 97:547-50. 2011
    ....
  4. ncbi Accuracy of prostate volume measurements using transrectal multiplanar three-dimensional sonography
    Gianluca Giubilei
    Department of Urology, University of Florence, Florence, Italy
    Int J Urol 12:936-8. 2005
    ....
  5. ncbi Prostate cancer specific mortality in the Florence screening pilot study cohort 1992-1993
    Stefano Ciatto
    Centro per lo Studio e la Prevenzione Oncologica, Viale A Volta 171, 50131 Firenze, Italy
    Eur J Cancer 42:1858-62. 2006
    ..99; 95% CI=0.69-1.37). This finding might suggest a screening effect, but might also be ascribed to an healthy screening effect, and cannot be assumed as a reliable evidence of screening efficacy...
  6. ncbi Current cancer profiles of the Italian regions: should cancer incidence be monitored at a national level?
    Stefano Ciatto
    Department of Diagnostic Imaging, CSPO, Istituto per la Prevenzione Oncologica, Florence, Italy
    Tumori 93:529-31. 2007
  7. ncbi Determining overdiagnosis by screening with DRE/TRUS or PSA (Florence pilot studies, 1991-1994)
    Stefano Ciatto
    Centro per lo Studio e la Prevenzione Oncologica, Viale A Volta 171, 50131 Florence, Italy
    Eur J Cancer 41:411-5. 2005
    ..23 in subjects excluded from invitation due to previous cancer or major illness (95%CI=0.8-1.5). A 66% excess incidence rate was observed in the screened subjects over a 9-year period, confirming previous estimates of overdiagnosis...
  8. ncbi Reliability of sparing Papanicolaou test conventional reading in cases reported as No Further Review at AutoPap-assisted cytological screening: survey of 30,658 cases with follow-up cytological screening
    Grazia Maria Troni
    Istituto Scientifico Prevenzione Oncologica CSPO, Florence, Italy
    Cancer 111:93-8. 2007
    ..AutoPap-assisted smear reading has been proposed prior to conventional manual reading; the latter may be unnecessary for cases reported as No Further Review (NFR) and would be required for cases reported as Review (REV)...
  9. ncbi PSA use and incidence of prostate biopsy in the Tuscany region: is opportunistic screening discounting biopsy in subjects with PSA elevation?
    Stefano Ciatto
    CSPO, Istituto Scientifico per la Prevenzione Oncologica, Florence, Italy
    Tumori 94:518-22. 2008
    ..To assess PSA use in the general population and estimate biopsy rate subsequent to opportunistic screening...
  10. ncbi Quality control of the autopap screening system employed as a primary screening device: rapid review of smears coded as no further review
    Paolo Bulgaresi
    Centro per lo Studio e la Prevenzione Oncologica, Florence, Italy
    Tumori 92:276-8. 2006
    ..The aim of the present study was to evaluate the usefulness of rapid review of all smears coded as "no further review" (NFR) by the AutoPap system as a quality control procedure...
  11. ncbi Interval breast cancers in screening: the effect of mammography review method on classification
    Stefano Ciatto
    Centro per lo Studio e la Prevenzione Oncologica, Viale A Volta 171, 5131, Florence, Italy
    Breast 16:646-52. 2007
    ..Due to expected variability, review methods need standardisation to improve screening quality. Our data support blinded review of IC in mammography screening...
  12. ncbi Full-field digital versus screen-film mammography: comparative accuracy in concurrent screening cohorts
    Marco Rosselli Del Turco
    Centro per lo Studio e la Prevenzione Oncologica, Viale A Volta 171, 50131 Florence, Italy
    AJR Am J Roentgenol 189:860-6. 2007
    ..The purpose of this study was to compare the diagnostic accuracy of digital mammography with that of screen-film mammography in concurrent cohorts participating in the same population-based screening program...
  13. ncbi Comparison of two commercial systems for computer-assisted detection (CAD) as an aid to interpreting screening mammograms
    Stefano Ciatto
    Centro per lo Studio e la Prevenzione Oncologica, Firenze, Italy
    Radiol Med 107:480-8. 2004
    ..To compare the diagnostic accuracy of two commercial CAD systems (CADx and R2) and their impact as an aid to conventional reading of screening mammograms...
  14. ncbi Mammography screening in elderly women: efficacy and cost-effectiveness
    Marco Zappa
    Descriptive and Epidemiological Unit, Center for Study and Prevention of Cancer CSPO, Scientific Institute of Tuscany Region, Via di San Salvi, 12, 50135, Florence, Italy
    Crit Rev Oncol Hematol 46:235-9. 2003
    ..Over the age of 74 years, encouraging individualized decisions may be more appropriate and may indicate further screening for those subjects for whom the potential benefit outweighs the potential negative effects...
  15. ncbi A feasibility study of the use of the AutoPap screening system as a primary screening and location-guided rescreening device
    Massimo Confortini
    Cytology Unit, Centro per lo Studio e la Prevenzione Oncologica, Florence, Italy
    Cancer 99:129-34. 2003
    ..Burlington, NC) is an automated device that was designed to screen conventionally prepared cervical smears and, more recently, thin-layer slide preparations. The system has been tested in large clinical trials...
  16. ncbi Free to total PSA ratio is not a reliable predictor of prostate biopsy outcome
    Stefano Ciatto
    Centro per lo Studio e la Prevenzione Oncologica, Florence, Italy
    Tumori 90:324-7. 2004
    ..The aim of this study was to assess the validity of predictors of prostate biopsy outcome in order to improve their positive predictive value...
  17. ncbi Persistent human papilloma virus infection as an indicator of risk of recurrence of high-grade cervical intraepithelial neoplasia treated by the loop electrosurgical excision procedure
    Silvia Cecchini
    Centro per lo Studio e la Prevenzione Oncologica, Florence, Italy
    Tumori 90:225-8. 2004
    ..To evaluate the recurrence rate of high-grade cervical intraepithelial neoplasia (CIN) treated by the loop electrosurgical excision procedure (LEEP) according to the persistence of human papilloma virus (HPV) infection...
  18. pmc Cervical intraepithelial neoplasia and higher long term risk of cancer
    Guglielmo Ronco
    BMJ 335:1053-4. 2007
  19. doi Ultrasound and mammography for breast cancer screening
    Nehmat Houssami
    JAMA 300:1514-5; author reply 1515. 2008
  20. ncbi [Interval cancers as indicators of performance in screening programmes]
    Stefano Ciatto
    Epidemiol Prev 32:93-8. 2008
    ....
  21. ncbi [Recommendations of a national Italian consensus conference on the opportunity of extending screening service by mammography to 40-49 and 70-74 years of age women]
    Vito Distante
    SOD Chirurgia generale II, AO universitaria, Careggi, Firenze
    Epidemiol Prev 31:15-22. 2007
    ....
  22. ncbi Quality control of mammography screening in the Veneto Region. Evaluation of four programs at a local health unit level--analysis of the frequency and diagnostic pattern of interval cancers
    Marcello Vettorazzi
    Registro Tumori Veneto, Padova, Italy
    Tumori 92:1-5. 2006
    ..The aim of this study was to evaluate the sensitivity of the mammography screening program in four Local Health Units (ASL) and the possible causes of diagnostic error in cases further surfacing as interval cancers...
  23. ncbi Radiological surveillance of interval breast cancers in screening programmes
    Nehmat Houssami
    Screening and Test Evaluation Program STEP, School of Public Health, University of Sydney, New South Wales, Australia
    Lancet Oncol 7:259-65. 2006
    ..Standardised radiological surveillance of interval cancers might allow within-programme comparisons and has the potential to guide practice and improve quality...
  24. ncbi Detection rates of high-grade prostate cancer during subsequent screening visits. Results of the European Randomized Screening Study for Prostate Cancer
    Theodorus H van der Kwast
    Department of Pathology and Urology, Erasmus Medical Center, Rotterdam, The Netherlands, and Centro per la Studio e la Prevenzione Oncologica, University of Florence, Italy
    Int J Cancer 118:2538-42. 2006
    ..e. 507/10,000 men). Variations in detection rates among screening centers related among others to biopsy compliance and age range...
  25. ncbi Quality assessment of the mammographic screening programme in the Azienda Sanitaria locale Provincia Milano 1 -- analysis of interval cancers and discussion of possible causes of diagnostic error
    Rossella Burani
    Azienda Sanitaria Locale Provincia Milano, Milan
    Radiol Med 109:260-7. 2005
    ..To evaluate the sensitivity of the mammographic screening programme and the causes of diagnostic fault in cases surfacing as interval cancers...
  26. ncbi Increasing trends of cervical adenocarcinoma incidence in Central Italy despite Extensive Screening Programme, 1985-2000
    Carmen B Visioli
    Descriptive and Epidemiological Unit, Center for Study and Prevention of Cancer CSPO, Via di San Salvi, 12, 50135 Florence, Italy
    Cancer Detect Prev 28:461-4. 2004
    ..The burden of cervical cancers might increase in the future if no specific preventive strategies for adenocarcinoma are implemented...
  27. ncbi [Prostate-specific antigen: appropriate and inappropriate use]
    Stefano Ciatto
    U O Diagnostica per Immagini, Centro per lo Studio e la Prevenzione Oncologica, Universita, Firenze
    Recenti Prog Med 94:95-8. 2003
    ..If opportunistic screening can not be avoided, we should at least avoid too an aggressive diagnostic approach (e.g. random biopsy for borderline [4-10 ng/ml] PSA values)...
  28. ncbi Determining the sensitivity of transrectal ultrasonography on a consecutive series of prostate cancers in a clinical and screening setting
    Stefano Ciatto
    Tumori 88:281-3. 2002
    ..To evaluate the sensitivity at transrectal ultrasonography (TRUS) for prostate cancer...
  29. ncbi Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial
    Harry J de Koning
    Department of Public Health, Erasmus University Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands
    Int J Cancer 97:237-44. 2002
    ..The differences between countries seem to reflect both underlying prostate cancer incidence and screening policy. The trials have the power to show definitive results in 2005-2008...